In brief

On 10 November 2022, the National Coordination Centre for Ethics Committees (“Centre“) published the updated versions of the “Contract for the performance of clinical trials on medicines,” the “Contract for the performance of independent clinical trials on medicines” and the “Contract for the performance of clinical investigations on medical devices that are not CE marked or CE marked but used outside their intended use.”

Key takeaways

In particular, the updates relate to: (i) the expenses borne by the patient (Article 6.9), in relation to which it is now possible to indemnify the expenses and loss of earnings incurred by the patient and directly related to the participation in the trial/investigation; (ii) the conclusion of the trial (Article 9.2), by requiring the transmission of the results to the EU database, within one year of its conclusion, regardless of the outcome; (iii) the patenting of inventions (Article 9.4), where it is specified that the institution may use the investigator’s data and results only for scientific and research purposes and that the promoter’s intellectual property rights should never be jeopardised; (iv) the choice of law (Article 16.2), which is now left to the parties, although it is recommended to prefer the law of the promoter’s place of business.

Last, the Centre also published the new template on “Contract for conducting clinical investigation to further evaluate the conformity of a CE marked medical device used within its intended use,” which is intended for post-marketing clinical follow-up investigations pursuant to Article 74, Section 1 of Regulation EU 2017/745.

Copyright © 2022 Baker & McKenzie. All rights reserved. Ownership: This documentation and content (Content) is a proprietary resource owned exclusively by Baker McKenzie (meaning Baker & McKenzie International and its member firms). The Content is protected under international copyright conventions. Use of this Content does not of itself create a contractual relationship, nor any attorney/client relationship, between Baker McKenzie and any person. Non-reliance and exclusion: All Content is for informational purposes only and may not reflect the most current legal and regulatory developments. All summaries of the laws, regulations and practice are subject to change. The Content is not offered as legal or professional advice for any specific matter. It is not intended to be a substitute for reference to (and compliance with) the detailed provisions of applicable laws, rules, regulations or forms. Legal advice should always be sought before taking any action or refraining from taking any action based on any Content. Baker McKenzie and the editors and the contributing authors do not guarantee the accuracy of the Content and expressly disclaim any and all liability to any person in respect of the consequences of anything done or permitted to be done or omitted to be done wholly or partly in reliance upon the whole or any part of the Content. The Content may contain links to external websites and external websites may link to the Content. Baker McKenzie is not responsible for the content or operation of any such external sites and disclaims all liability, howsoever occurring, in respect of the content or operation of any such external websites. Attorney Advertising: This Content may qualify as “Attorney Advertising” requiring notice in some jurisdictions. To the extent that this Content may qualify as Attorney Advertising, PRIOR RESULTS DO NOT GUARANTEE A SIMILAR OUTCOME. Reproduction: Reproduction of reasonable portions of the Content is permitted provided that (i) such reproductions are made available free of charge and for non-commercial purposes, (ii) such reproductions are properly attributed to Baker McKenzie, (iii) the portion of the Content being reproduced is not altered or made available in a manner that modifies the Content or presents the Content being reproduced in a false light and (iv) notice is made to the disclaimers included on the Content. The permission to re-copy does not allow for incorporation of any substantial portion of the Content in any work or publication, whether in hard copy, electronic or any other form or for commercial purposes.


Roberto Cursano leads the Rome Healthcare and Life Sciences practice.


Riccardo Ovidi can be reached at